ARDT
Ardent Health Partners, Inc.
NYSE: ARDT · HEALTHCARE · MEDICAL CARE FACILITIES
$9.95
+0.93% today
Updated 2026-06-05
Market cap
$1.32B
P/E ratio
9.72
P/S ratio
0.21x
EPS (TTM)
$0.95
Dividend yield
—
52W range
$8 – $15
Volume
0.4M
WallStSmart proprietary scores
49
out of 100
Grade: C
Sell
Investment rating
4.7
Growth
C7.0
Quality
B+5.0
Profitability
C+6.7
Valuation
B4/9
Piotroski F-Score
Moderate
2.0
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$12.50
+25.63%
12-Month target
$7.03
-29.35%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy4 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at 2.09%
- Negative free cash flow $-88.31M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.13B | $5.41B | $5.97B | $6.32B | $6.43B |
| Net income | $188.91M | $50.29M | $210.34M | $135.81M | $39.85M |
| EPS | — | — | — | — | $0.95 |
| Free cash flow | $-189.47M | $84.29M | $127.52M | $258.61M | $-88.31M |
| Profit margin | 3.68% | 0.93% | 3.53% | 2.15% | 2.09% |
Peer comparison
Smart narrative
Ardent Health Partners, Inc. trades at $9.95. representing a P/E of 9.72x trailing earnings. Our Smart Value Score of 49/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.04, it sits in the grey zone. TTM revenue stands at $6.43B. with profit margins at 2.09%.
Frequently asked questions
What is Ardent Health Partners, Inc.'s stock price?
Ardent Health Partners, Inc. (ARDT) trades at $9.95, on a P/E of 9.7x and a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Ardent Health Partners, Inc. overvalued?
Ardent Health Partners, Inc. carries a Smart Value Score of 49/100 (Grade C), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Ardent Health Partners, Inc. (ARDT)?
The 12-month analyst consensus target is $12.50, about 25.6% above the current $9.95. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Ardent Health Partners, Inc.'s revenue?
Ardent Health Partners, Inc.'s trailing twelve-month revenue is $6.43B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Ardent Health Partners, Inc.'s Altman Z-Score is 2.04, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.21x
ROE7.74%
Beta—
50D MA$9.44
200D MA$10.61
Shares out0.14B
Float0.02B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—